Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | calcium channel, voltage-dependent, alpha 2/delta subunit 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | voltage dependent calcium channel subunit | Get druggable targets OG5_133164 | All targets in OG5_133164 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | Get druggable targets OG5_133164 | All targets in OG5_133164 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Cache domain containing protein | calcium channel, voltage-dependent, alpha 2/delta subunit 1 | 1091 aa | 1161 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0029 | 0.0173 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0029 | 0.0173 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.1608 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0029 | 0.0173 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0202 | 0.4271 | 0.4271 |
Schistosoma mansoni | hypothetical protein | 0.0193 | 0.4071 | 0.9988 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0193 | 0.4071 | 0.9988 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0098 | 0.1803 | 0.4423 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0029 | 0.0173 | 1 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0202 | 0.4271 | 0.4271 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0193 | 0.4076 | 1 |
Brugia malayi | hypothetical protein | 0.0029 | 0.0173 | 0.1076 |
Echinococcus multilocularis | geminin | 0.0193 | 0.4071 | 0.4071 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0029 | 0.0173 | 1 |
Echinococcus granulosus | geminin | 0.0193 | 0.4071 | 0.4071 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0173 | 0.1076 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0443 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0.0173 | 1 |
Brugia malayi | Cache domain containing protein | 0.0089 | 0.1608 | 1 |
Schistosoma mansoni | serine-rich repeat protein | 0.0104 | 0.196 | 0.4809 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.196 | 0.4809 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.0173 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.0173 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 829 nM | Binding affinity against alpha2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human | ChEMBL. | 15109633 |
IC50 (binding) | = 829 nM | Binding affinity against alpha2 delta-1 subunit of voltage gated subunit of Ca+2 channel in human | ChEMBL. | 15109633 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.